A New Molecular Target of Insulin Action: Regulating the Pivotal PDK1

Publisher： Bentham Science Publishers

E-ISSN： 1875-5917|1|3|209-221

ISSN： 1568-0088

Source： Current Drug Targets - Immune, Endocrine & Metabolic Disorders, Vol.1, Iss.3, 2001-11, pp. : 209-221

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

NF- B: a pivotal role in asthma and a new target for therapy

By Barnes P.J.   Adcock I.M.  

Trends in Pharmacological Sciences, Vol. 18, Iss. 2, 1997-02 ,pp. : 46-50

Elsevier

Access to resources Recommend Favorite

Targeting PDK1 in Cancer

By  

Current Medicinal Chemistry, Vol. 18, Iss. 18, 2011-06 ,pp. : 2763-2769

Bentham Science Publishers

Access to resources Recommend Favorite

PD-1/PD-Ls: A New Target for Regulating Immunopathogenesis in Central Nervous System Disorders

By  

Current Drug Delivery, Vol. 14, Iss. 6, 2017-09 ,pp. : 791-796

Bentham Science Publishers

Access to resources Recommend Favorite

Apoptosis signal-regulating kinase 1 as a therapeutic target

By Kawarazaki Yosuke   Ichijo Hidenori   Naguro Isao  

Expert Opinion on Therapeutic Targets, Vol. 18, Iss. 6, 2014-06 ,pp. : 651-664

Informa Healthcare

Access to resources Recommend Favorite

STAT1 as a New Molecular Target of Anti-Inflammatory Treatment

By  

Current Medicinal Chemistry, Vol. 12, Iss. 16, 2005-08 ,pp. : 1819-1828

Bentham Science Publishers

Access to resources Recommend Favorite